Recent Price Movement and Market Context
On 9 March 2026, Dishman Carbogen Amcis Ltd opened with a gap down of -2.26% and continued to slide throughout the trading session, hitting an intraday low of Rs.154.7, a decline of -5.56% from the previous close. The stock underperformed its sector by -3.92% and has recorded losses over the last two consecutive days, falling by -5.27% in that period. This downward momentum places the share price well below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish sentiment.
The broader market environment has also been challenging. The Sensex opened sharply lower at 77,056.75, down by -1,862.15 points (-2.36%), and was trading at 77,166.04 (-2.22%) during the same session. The index has experienced a three-week consecutive decline, losing -6.82% over this period. Meanwhile, the INDIA VIX index reached a new 52-week high, indicating elevated market volatility and investor caution.
Financial Performance and Fundamental Metrics
Dishman Carbogen Amcis Ltd’s financial indicators continue to reflect pressure. The company reported a quarterly Profit After Tax (PAT) of Rs. -12.97 crores, representing a steep fall of -403.0%. Operating profit to interest coverage ratio has dropped to a low of 2.47 times, while quarterly PBDIT stands at Rs.113.11 crores, also at a low point. These figures highlight the strain on profitability and the company’s ability to cover interest expenses comfortably.
Long-term fundamentals remain weak, with an average Return on Capital Employed (ROCE) of just 0.97%, indicating limited efficiency in generating returns from capital investments. Net sales growth has been modest, averaging 8.10% annually over the past five years, which is below sector expectations. The company’s debt servicing capacity is also a concern, with a high Debt to EBITDA ratio of 4.96 times, suggesting elevated leverage and potential financial risk.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Shareholder and Institutional Participation
Institutional investors have reduced their holdings in Dishman Carbogen Amcis Ltd by -0.51% over the previous quarter, now collectively holding 8.93% of the company’s shares. This decline in institutional participation may reflect concerns about the company’s financial trajectory and growth prospects, given these investors’ typically rigorous fundamental analysis capabilities.
Comparative Performance and Valuation
Over the past year, the stock has delivered a negative return of -26.61%, significantly underperforming the Sensex, which gained 3.81% during the same period. The stock has also lagged behind the BSE500 index over the last three years, one year, and three months, indicating persistent underperformance relative to broader market benchmarks.
Despite these challenges, the company’s valuation metrics present some contrasting signals. With a ROCE of 3.2 and an enterprise value to capital employed ratio of 0.5, Dishman Carbogen Amcis Ltd is trading at a discount compared to its peers’ historical averages. Additionally, the company’s profits have risen by 233.1% over the past year, resulting in a low PEG ratio of 0.1, which may suggest that the market is pricing in subdued growth expectations.
Sector and Market Dynamics
The Pharmaceuticals & Biotechnology sector continues to face volatility amid global economic uncertainties and evolving regulatory landscapes. Dishman Carbogen Amcis Ltd’s performance must be viewed within this context, where sector peers have shown varying degrees of resilience and growth. The company’s current market capitalisation grade stands at 3, reflecting moderate size and liquidity considerations within the sector.
Why settle for Dishman Carbogen Amcis Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Mojo Score and Rating Update
Dishman Carbogen Amcis Ltd currently holds a Mojo Score of 17.0 and a Mojo Grade of Strong Sell, upgraded from a previous Sell rating as of 12 January 2026. This rating reflects the company’s weak long-term fundamentals, including low return on capital and high leverage, which continue to weigh on investor sentiment and stock performance.
Summary of Key Metrics
The stock’s 52-week high stands at Rs.321.15, highlighting the extent of the recent decline to Rs.154.7. The day’s low of Rs.154.7 represents a -5.56% drop intraday, with a day change of -3.69%. The stock’s underperformance relative to the sector and broader market indices underscores the challenges faced by the company in maintaining competitive momentum.
Overall, Dishman Carbogen Amcis Ltd’s share price movement to a new 52-week low is a reflection of multiple factors, including subdued financial results, reduced institutional interest, and broader market pressures. The company’s valuation metrics and profit growth present a complex picture, but the prevailing market conditions and fundamental indicators have contributed to the current price levels.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
